Quelles sont les heures d'ouverture ?

Lundi 8am - 6pm Mardi 8am - 6pm Mercredi 8am - 6pm Jeudi 8am - 6pm Vendredi 8am - 6pm

CellCarta

Name: CellCarta
Address: 201 President Kennedy Avenue , Suite 3900, Montreal, QC, H2X3Y7, CA
Telephone: +15143603600
Price range: $$

CellCarta, formely Caprion-HistoGenex CellCarta, formely Caprion-HistoGeneX.

CellCarta is a leading provider of specialized precision medicine laboratory services to the biopharmaceutical industry. Leveraging its integrated analytical platforms in immunology, histopathology, proteomics and genomics, as well as related specimen collection and logistics services, CellCarta supports the entire drug development cycle, from discovery to late stage clinical trials. The company operates globally with 9 facilities located in Canada, USA, Belgium, Australia, and China.

08/31/2026

Need a panel tailored to your protocol's exact genomic coverage? Our team designs, validates, and operationalizes custom NGS assays across our global labs, with fully-owned genomics labs in North America, Europe, and China. Talk to us about building the right assay for your trial.

https://buff.ly/jieim7F

08/27/2026

Choosing the right biomarker and clinical testing strategy can be the difference between a promising therapy reaching patients or stalling before it gets there.

For over 25 years, CellCarta has brought scientific rigor to the full spectrum of biomarker development, from discovery through companion diagnostics.

More expertise. More confidence in your data. More certainty in your next step.

Because when your science demands more, CellCarta delivers.

https://buff.ly/9NN2uPS

08/26/2026

Unlock deep insight from small sample volumes with Olink® proteomic assays. As a certified service provider, including at our lab in China, we offer flexible panels from 48 to over 1000 analytes with rapid turnaround.

Discover all our proteomic biomarker quantification options here:
https://buff.ly/x32XMCY

08/24/2026

From chemotherapy to bispecific antibodies: lung cancer treatment has been transformed in a single generation. In our next Let's Talk webcast, Christopher Ung sits down with Professor Caicun Zhou, Director of Oncology at Shanghai East Hospital and Director of the Tongji University Cancer Institute, for a conversation on where the field is headed.

Professor Zhou is the principal investigator of the HARMONi-2 trial, evaluating Ivonescimab against Pembrolizumab in NSCLC, and one of the most respected voices in global oncology.

He joins our Chief Scientific Business Officer, Christopher Ung, to discuss:

🧬 His path from pulmonologist to leading lung cancer clinical trial investigator

🧬 The shift from chemotherapy to targeted therapy and immunotherapy

🧬 What the HARMONi-2 results mean for the future of PD-1-VEGF bispecific antibodies

🧬 Why China is emerging as a major force in oncology innovation

Stay tuned for the full webcast.

08/19/2026

Discover our new look! Our new website is making it easier than ever to discover the integrated biomarker, regulatory and logistics services that accelerate your clinical programs.

Check it out! https://buff.ly/tdHq3s1

08/17/2026

We were thrilled to welcome members of the CellCarta community to our new Montreal Laboratory and Global Headquarters for our official Grand Opening. Together with colleagues, our senior leadership team, our board members, collaborators and local members of Montreal's scientific community, we celebrated the official launch of our new global headquarters, with speeches and a ribbon cutting by our CEO Dusty Tenney, Co-Founder Martin LeBlanc, and SVP of Immunology and Proteomics, Todd Chermak.

This new lab is a state-of-the-art facility, and is not only the new home of our immunology and proteomics laboratories in Montreal, but a direct investment in delivering greater impact to our biopharma partners.

Our headquarters aren't the only place with a new look. Check out our updated website to see how we're making it easier than ever to find out how we can accelerate your program goals. 👉 https://buff.ly/tdHq3s1

Thanks to everyone who made this event possible!

08/13/2026

Are you or your collaborators in Beijing? CellCarta is hosting an ADC focused symposium on September 21st, and we'd love to see you there.

Join us for an afternoon focused on Advancing Biomarker Innovation in the ADC Era: HER2, TROP2, CLDN18.2 and other emerging biomarkers driving the next generation of ADC development.

This event features pathology, clinical, industry and translational perspectives, with speakers from leading hospitals and biotech companies.

Register now: https://buff.ly/m1bPkFp

08/07/2026

Changing gate positions manually can make your cytometry analysis take orders of magnitude longer. Now, easier and simpler analysis is within reach!

Automatic gating tools are available in CellEngine, our cytometry analysis platform. Using machine learning algorithms, it adjusts gate placement to fit sample data, speeding up your analysis.

Want to learn more? Check it our for yourself👉 https://buff.ly/0b7Ja8o

08/04/2026

CellCarta is proud to expand its advanced proteomics capabilities with the addition of the Thermo Scientific Orbitrap Excedion Pro, now fully operational in our mass spectrometry suite.

Equipped with FAIMS, this next-generation platform enables enhanced selectivity and sensitivity, empowering deeper and more confident unbiased proteomics and characterization of complex biomolecules.

For sponsors managing complex modalities on tight regulatory timelines, this means data you can trust, faster. Reach out to our team to learn how unbiased mass spec can deliver the analytical data you need: https://buff.ly/4ftFrmb

07/31/2026

We will be presenting at the 9th Immuno-Oncology & CDx Co-Development Conference in Shanghai. We hope to see you there!

CellCarta’s Michelle Li will be presenting on how to navigate the IHC assay journey in global drug development- from patient selection to companion diagnostics. Get expert insight into the considerations for using IHC assays for patient selection in clinical trials, the regulatory expectations and quality requirements, and strategies for harmonizing assay development across global regulatory frameworks to support global trials and future CDx approvals.

Not sure you will make the presentation? Message our team to learn more about how we can help navigate global drug development, including in China, with globally harmonized SOPs and a fully owned laboratory in China.

👨‍🔬👩‍🔬https://buff.ly/aOjKOCh

Adresse

201 President Kennedy Avenue , Suite 3900
Montreal, QC
H2X3Y7

Heures d'ouverture

Lundi	8am - 6pm
Mardi	8am - 6pm
Mercredi	8am - 6pm
Jeudi	8am - 6pm
Vendredi	8am - 6pm

Téléphone

+15143603600

Site Web

https://cellcarta.com/

Notifications

Soyez le premier à savoir et laissez-nous vous envoyer un courriel lorsque CellCarta publie des nouvelles et des promotions. Votre adresse e-mail ne sera pas utilisée à d'autres fins, et vous pouvez vous désabonner à tout moment.